Literature DB >> 6176597

Protein contents and binding modes of immunoglobulin-amylase complexes.

H Ohtani, K Sakaguchi, M Saito.   

Abstract

The protein contents and binding modes of immunoglobulin-amylase complexes were investigated. Amylase staining after immunoelectrophoresis permitted identification of IgA-lambda type in three cases, IgA-kappa type in two cases and IgG-kappa type in one case. The precipitin line of Fab fragment of IgA in four patient's sera after papain digestion was found to have amylase activity. Sucrose density gradient ultracentrifugation studies showed that these complexes were divided into three groups: Group I complexes were dissociated in acid pH, and at pH 7.0 the immunoglobulins, which were isolated at the acid pH, became rebound to serum amylase; Group II complexes were dissociated by acidification, but did not reform at pH 7.0; Group III complexes were unaffected by acidification. We suggest that the immunoglobulin-amylase complexes belonging to groups I and II result from an antigen-antibody reaction. Precipitin curves resulting from the addition of increasing quantities of the patient's serum containing 9 S or 11 S immunoglobulin-amylase complexes to specific antisera revealed that these complexes contained not only monoclonal IgA, but also alpha-1-antitrypsin (alpha 1 AT) and albumin. These IgA complexes could have bound non-specifically to alpha 1 AT and albumin, forming the larger macroamylase complexes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176597      PMCID: PMC497666          DOI: 10.1136/jcp.35.4.385

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Binding of albumin to gamma-A-myeloma proteins and Waldenström macroglobulins by disulfide bonds.

Authors:  M Mannik
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

2.  Macroamylasemia: a newly recognized cause for elevated serum amylase activity.

Authors:  J E Berk; H Kizu; P Wilding; R L Searcy
Journal:  N Engl J Med       Date:  1967-11-02       Impact factor: 91.245

3.  Hyperamylasemia from the binding of serum amylase by an 11S IgA globulin.

Authors:  M D Levitt; S R Cooperband
Journal:  N Engl J Med       Date:  1968-02-29       Impact factor: 91.245

4.  Two forms of macroamylasaemia.

Authors:  M D Levitt; E J Goetzl; S R Cooperband
Journal:  Lancet       Date:  1968-05-04       Impact factor: 79.321

5.  Macroamylasemia due to binding by protein.

Authors:  H R Hansen; H Van Kley; W A Knight
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

6.  Ultracentrifugal characteristics of macroamylasemic serum.

Authors:  M Ueda; J E Berk; L Fridhandler; J Davis
Journal:  Clin Chim Acta       Date:  1971-12       Impact factor: 3.786

7.  Macroamylasemia: variation in the response of the macroamylase complex to acidification.

Authors:  M Ueda; J E Berk; L Fridhandler
Journal:  Proc Soc Exp Biol Med       Date:  1971-09

8.  Macroamylasemia: possible role of polysaccharide in composition of macroamylase.

Authors:  S Take; L Fridhandler; J E Berk
Journal:  Clin Chim Acta       Date:  1970-02       Impact factor: 3.786

9.  Immunochemical properties of human gamma A isoagglutinin. II. The effect of reduction and alkylation.

Authors:  K Ishizaka; T Ishizaka; E H Lee
Journal:  J Immunol       Date:  1965-11       Impact factor: 5.422

10.  A subclass of human gamma-A-globulins (gamma-A2) which lacks the disulfied bonds linking heavy and light chains.

Authors:  H M Grey; C A Abel; W J Yount; H G Kunkel
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.